Transcript THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS
THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS
A DUTCH POPULATION BASED STUDY
Myrella Vlenterie, SEJ Kaal, VKY Ho, R Vlenterie, WTA van der Graaf Medical Oncology, Radboud University Medical Centre, Nijmegen
Literature
Literature
Research question
• Is age an independent prognostic factor for overall and relative survival in synovial sarcoma patients?
Research question
• Is age an independent prognostic factor for overall and relative survival in synovial sarcoma patients?
• Do treatment modalities explain the differences between variant age groups?
Materials & Methods
• The Netherlands Cancer Registry: • >95% coverage • Information at diagnosis • • Tumour and patient characteristics, diagnostics and therapy Sources: Dutch pathology network (PALGA) & hospital records
Materials & Methods
• The Netherlands Cancer Registry: • >95% coverage • Information at diagnosis • • Tumour and patient characteristics, diagnostics and therapy Sources: Dutch pathology network (PALGA) & hospital records • Cancer care in the Netherlands • Sarcoma care centralised in recent years
Materials & Methods
• The Netherlands Cancer Registry: • >95% coverage • Information at diagnosis • • Tumour and patient characteristics, diagnostics and therapy Sources: Dutch pathology network (PALGA) & hospital records • Cancer care in the Netherlands • Sarcoma care centralised in recent years • Statistics: • • • • Kaplan Meier for Overall survival (OS) Relative survival (RS) Univariate analyses Multivariate Cox regression analyses
Age groups Children
< 18years
Adults
35-64years
AYAs
18-34years
Elderly
≥65years
Patient cohort Patients histologically diagnosed with SS: 1989-2012
102 (17%) 46 (8%) 438 (75%) Localized disease Metastatic disease Unknown Total: 586 patients
Overall survival: stage at diagnosis
• Median follow up: 42 months (range 0-300 months) No metastasis 5yr OS: 64±2% Unknown stage Metastases median survival: 11±1months
Survival time (months)
Localised disease
Patient characteristics Variable
Age Sex Histology Hospital of surgery o o o o o o o o o o o o <18 years 18-34 years 35-64 years ≥65 years Male Female Monophasic Biphasic
Not specified
General hospital Academic hospital
Unknown
n = 438
51 143 192 52 236 202 95 98 245 108 196 134
(100%)
(12%) (33%) (44%) (12%) (54%) (46%) (22%) (22%) (56%) (25%) (45%) (31%)
Patient characteristics Variable
Site of origin Therapy Resection status o o o o o o o o o o o Extremities Head and neck Trunk Other Surgery alone Surgery + RT (+CT) Surgery + CT No surgery R0 R1 / R2
R status unknown
n = 438
294 36 78 30 151 206 38 43 135 51 252
(100%)
(67%) (8%) (18%) (7%) (35%) (47%) (9%) (10%) (31%) (12%) (58%)
Overall survival: age groups
5yr OS: 91±4% Children 5yr OS: 72±4% 5yr OS: 57±4% 5yr OS: 43±7% AYAs Adults Elderly
Survival time (months)
Relative survival: age groups
5yr OS: 91%
5yr RS: 91%
5yr OS: 72%
5yr RS: 72%
5yr OS: 57%
5yr RS: 58%
5yr OS: 43%
5yr RS: 53%
Children AYAs Adults Elderly RS: Corrected for age, sex and year
Age as a continous variable Age (years)
Cox regression: Univariate analyses Variables
Age groups Sex Histology Hospital of surgery Site of origin Therapy Resection status
Cox regression: Univariate analyses Variables
Age groups Sex Histology Hospital of surgery Site of origin Therapy Resection status p < 0.10
Cox regression: Univariate analyses Variables
Age groups Sex Histology Hospital of surgery Site of origin Therapy Resection status p < 0.10
Cox regression: Univariate analyses Variables
Age groups Sex Histology Hospital of surgery Site of origin Therapy Resection status p < 0.10
Treatment modalities
*Chi-square: p<0.05
* 100% Surgery + CT 80% 60% 40% 20% 0% Surgery + RT (+CT) Surgery alone Total Children AYAs Adults Elderly 43 patients received no surgery left out of multivariate analysis
Cox regression: Multivariate analysis Age groups
Children AYAs Adults Elderly
Treatment
Surgery alone Surgery + (neo)adj radiotherapy* Surgery + (neo)adj chemotherapy
Primary localisation
Extremities Head and neck Trunk Other 0,1 1,0 10,0 49 1 136 2.26
171 3.81
39 6.52
151 1 206 0.93
38 1.75
n HR 279 1 33 1.05
60 1.97
23 2.04
Cox regression: Multivariate analysis Age groups
Children AYAs Adults Elderly
Treatment
Surgery alone Surgery + RT (+CT) Surgery + CT
Primary localisation
Extremities Head and neck Trunk Other 0,1 1,0 10,0 49 1 136 2.26
171 3.81
39 6.52
n HR 151 1 206 0.93
38 1.75
279 1 33 1.05
60 1.97
23 2.04
Cox regression: Multivariate analysis
n HR
Age groups
Children AYAs Adults Elderly 49 1 136 2.26
171 3.81
39 6.52
Treatment
Surgery alone Surgery + RT (+CT) Surgery + CT
Primary localisation
Extremities Head and neck Trunk Other 151 1 206 0.93
38 1.75
279 1 33 1.05
60 1.97
23 2.04
0,1 1,0 10,0
Take home messages
1.
Age at diagnosis is an independent prognostic factor for overall and relative survival 2.
Survival differences can not be explained by treatment modalities
Future research
• Further research in tumor biology is necessary to explain the survival differences